Balovaptan vs Placebo for Social Communication in Childhood Autism Spectrum Disorder-Reference-Cited by-同舟云学术

Balovaptan vs Placebo for Social Communication in Childhood Autism Spectrum Disorder

Published:2022-08-01 Issue:8 Volume:79 Page:760
ISSN:2168-622X
Container-title:JAMA Psychiatry
language:en
Short-container-title:JAMA Psychiatry

Author:

Hollander Eric¹,Jacob Suma²,Jou Roger³,McNamara Nora⁴,Sikich Linmarie⁵,Tobe Russell⁶,Smith Janice⁷,Sanders Kevin⁸,Squassante Lisa⁹,Murtagh Lorraine⁹,Gleissl Teresa⁹,Wandel Christoph⁹,Veenstra-VanderWeele Jeremy¹⁰

Affiliation:

1. Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, New York, New York

2. Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis

3. Child Study Center, Yale School of Medicine, New Haven, Connecticut

4. Department of Psychiatry, University Hospitals, Cleveland, Ohio

5. Department of Psychiatry and Behavioral Sciences, Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina

6. Nathan Kline Institute for Psychiatric Research, Orangeburg, New York

7. F. Hoffmann-La Roche Ltd, Welwyn Garden City, United Kingdom

8. F. Hoffmann-La Roche Ltd, Genentech, South San Francisco, California

9. F. Hoffmann-La Roche Ltd, Basel, Switzerland

10. Columbia University and New York State Psychiatric Institute, New York

Publisher

American Medical Association (AMA)

Subject

Psychiatry and Mental health

Link

https://jamanetwork.com/journals/jamapsychiatry/articlepdf/2793696/jamapsychiatry_hollander_2022_oi_220038_1659381711.12916.pdf

Reference33 articles.

1. Autism spectrum disorder: definition, epidemiology, causes, and clinical evaluation.;Hodges;Transl Pediatr,2020

2. Environmental and genetic factors in autism spectrum disorders: special emphasis on data from Arabian studies.;Almandil;Int J Environ Res Public Health,2019

3. Pharmacological therapies for autism spectrum disorder: a review.;LeClerc;P T,2015

4. Autism spectrum disorder: consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology.;Howes;J Psychopharmacol,2018

5. Neuromodulation by oxytocin and vasopressin.;Stoop;Neuron,2012

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery and evaluation of a novel 18F-labeled vasopressin 1a receptor PET ligand with peripheral binding specificity;Acta Pharmaceutica Sinica B;2024-09

2. Arginine vasopressin in mood disorders: A potential biomarker of disease pathology and a target for pharmacologic intervention;Psychiatry and Clinical Neurosciences;2024-06-25

3. Dietary nutrients that potentially mitigate autism spectrum disorder and dietary recommendations for children and pregnant women;Food Frontiers;2024-03-11

4. A population pharmacokinetics model of balovaptan to support dose selection in adult and pediatric populations;Journal of Pharmacokinetics and Pharmacodynamics;2024-02-03

5. Cannabinoid treatment for the symptoms of autism spectrum disorder;Expert Opinion on Emerging Drugs;2024-01-02